Yahoo! Finance: MYL News

3 Stocks Springing Back (at Motley Fool)

Wed, 6 Jan 2010 20:25:16 Etc/GMT

Generic-Drug Firms Prosper Amid Drive To Cut Health Costs (Investor's Business Daily)

Wed, 30 Dec 2009 23:00:35 Etc/GMT

Wade through all the fevered rhetoric surrounding health care reform, and you'll find one point 14early everyone agrees on: Anything that can...

[$$] The Fed Won't Hike Rates Anytime Soon (at RealMoney by TheStreet.com)

Wed, 30 Dec 2009 13:28:24 Etc/GMT

Watson Pharmaceuticals: Look-Ahead to December 2009 Quarterly Results (at Seeking Alpha)

Tue, 29 Dec 2009 09:18:33 Etc/GMT

Prospecting for Stocks: Mylan Laboratories (at Motley Fool)

Mon, 28 Dec 2009 18:51:48 Etc/GMT

FDA Delays Nuvigil Decision (Zacks.com)

Mon, 28 Dec 2009 16:04:34 Etc/GMT

FDA Backs Crestor's Wider Use (Zacks.com)

Mon, 28 Dec 2009 15:10:38 Etc/GMT

AstraZeneca received a positive opinion from the FDA panel regarding the expanded use of Crestor.

Many Reasons to Launch a Global Generic Drug ETF (at Seeking Alpha)

Thu, 24 Dec 2009 20:27:05 Etc/GMT

Vytorin Update: Cancer Risk, Generic Challenge (at The Wall Street Journal Online)

Tue, 22 Dec 2009 18:58:20 Etc/GMT

Big Pharmas Love-Hate With India (at Minyanville.com)

Tue, 22 Dec 2009 17:50:00 Etc/GMT

The country produces both competition and opportunity.

Mylan Receives Tentative FDA Approval Under PEPFAR for Matrix Laboratories' New Drug Application (NDA) for Efavirenz Tablets (PR Newswire)

Tue, 22 Dec 2009 13:00:00 Etc/GMT

Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received tentative approval from the U.S. Food and Drug Administration under the President's Emergency Plan for AIDS Relief for its New Drug Application for Efavirenz Tablets, 50 mg, 100 mg and 200 mg.

UPDATE - Mylan seeks approval of generic of Merck's Vytorin (at Reuters)

Tue, 22 Dec 2009 12:33:10 Etc/GMT

Mylan sued over plans for generic Vytorin (AP)

Tue, 22 Dec 2009 12:31:25 Etc/GMT

Mylan Inc. said Tuesday it being sued by Schering Corp. and MSP Singapore over plans to make a generic version of the cholesterol drug Vytorin.

Mylan Confirms First-to-File Patent Challenge Relating to Vytorin(R) Cholesterol Medication (PR Newswire)

Tue, 22 Dec 2009 12:00:00 Etc/GMT

Mylan Inc. today confirmed that the company and its subsidiary Mylan Pharmaceuticals Inc. have been sued by Schering Corporation and MSP Singapore Company in connection with the filing of an Abbreviated New Drug Application with the U.S.

UPDATE - Ratiopharm to beat own expectations for 2009 (at Reuters)

Tue, 22 Dec 2009 08:47:50 Etc/GMT

Mylan to Sponsor PGA TOUR's Nationwide Tour Event at Southpointe Golf Club in Early September (PR Newswire)

Thu, 17 Dec 2009 15:05:00 Etc/GMT

Mylan Inc. today announced that it will sponsor a PGA TOUR Nationwide Tour event -- the Mylan Classic -- at Southpointe Golf Club in the Pittsburgh suburb of Canonsburg in 2010.

Salix to File for IBS Indication (Zacks.com)

Wed, 16 Dec 2009 16:52:23 Etc/GMT

Large And Small Cap Picks In The Health Care Space: Credit Suisse Analyst Guides Investors On Which Stocks Are A Good Buy (Wall Street Transcript)

Mon, 14 Dec 2009 16:55:00 Etc/GMT

67 WALL STREET, New York - December 14, 2009 - The Wall Street Transcript has just published its Consumer Health Services Report offering a timely review of the sector to serious investors and industry executives. This 53 page feature contains expert industry commentary through in-depth interviews with public company CEOs, Equity Analysts and Money Managers. The full issue is available by calling (212) 952-7433 or via The Wall Street Transcript Online.

Stealth Generic Drug Play: 1 Minute Trade (TheStreet.com TV)

Mon, 14 Dec 2009 14:04:36 Etc/GMT

http://us.news2.yimg.com/us.yimg.com/p/fi/26/39/43.jpg/yfinance/tscm/strategysession/10643905http://www.thestreet.com/

Mylan Added to NASDAQ-100 Index (PR Newswire)

Mon, 14 Dec 2009 13:00:00 Etc/GMT

Mylan Inc. today announced that the company will be added to the NASDAQ-100 Index Dec. 21. Mylan's common shares will also be included in NASDAQ's PowerShares QQQ.